Imperial College London
Portrait Picture

Dr Alex Miras

Faculty of Medicine, Department of Metabolism, Digestion and Reproduction

Visiting Professor
 
 
 
//

Contact

 

+44 (0)7958 377 674a.miras

 
 
//

Location

 

Commonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Shibib:2022:10.2147/VHRM.S345810,
author = {Shibib, L and Al-Qaisi, M and Ahmed, A and Miras, AD and Nott, D and Pelling, M and Greenwald, SE and Guess, N},
doi = {10.2147/VHRM.S345810},
journal = {Vascular Health and Risk Management},
pages = {417--443},
title = {Reversal and remission of T2DM - an update for practitioners},
url = {http://dx.doi.org/10.2147/VHRM.S345810},
volume = {18},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Over the past 50 years, many countries around the world have faced an unchecked pandemic of obesity and type 2 diabetes (T2DM). As best practice treatment of T2DM has done very little to check its growth, the pandemic of diabesity now threatens to make health-care systems economically more difficult for governments and individuals to manage within their budgets. The conventional view has been that T2DM is irreversible and progressive. However, in 2016, the World Health Organization (WHO) global report on diabetes added for the first time a section on diabetes reversal and acknowledged that it could be achieved through a number of therapeutic approaches. Many studies indicate that diabetes reversal, and possibly even long-term remission, is achievable, belying the conventional view. However, T2DM reversal is not yet a standardized area of practice and some questions remain about long-term outcomes. Diabetes reversal through diet is not articulated or discussed as a first-line target (or even goal) of treatment by any internationally recognized guidelines, which are mostly silent on the topic beyond encouraging lifestyle interventions in general. This review paper examines all the sustainable, practical, and scalable approaches to T2DM reversal, highlighting the evidence base, and serves as an interim update for practitioners looking to fill the practical knowledge gap on this topic in conventional diabetes guidelines.
AU  - Shibib,L
AU  - Al-Qaisi,M
AU  - Ahmed,A
AU  - Miras,AD
AU  - Nott,D
AU  - Pelling,M
AU  - Greenwald,SE
AU  - Guess,N
DO  - 10.2147/VHRM.S345810
EP  - 443
PY  - 2022///
SN  - 1176-6344
SP  - 417
TI  - Reversal and remission of T2DM - an update for practitioners
T2  - Vascular Health and Risk Management
UR  - http://dx.doi.org/10.2147/VHRM.S345810
UR  - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000811882100001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR  - https://www.dovepress.com/reversal-and-remission-of-t2dm--an-update-for-practitioners-peer-reviewed-fulltext-article-VHRM
UR  - http://hdl.handle.net/10044/1/97966
VL  - 18
ER  -
Download